Overview

Optimized Treatment Strategies for Early and Medium Stage Nasopharyngeal Carcinoma

Status:
Recruiting
Trial end date:
2025-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to optimize treatment strategies for patients with stage II and III nasopharyngeal carcinoma, reduce the side effects related to treatment and improve the quality of life.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Chinese Academy of Medical Sciences
Treatments:
Cisplatin
Docetaxel